Clinical Trials Browser

Phase EARLY_PHASE1 × Withdrawn × Leukemia, Myeloid, Acute × Clear all

NCT03291353 2019-04-19

Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute